Gore Range Capital
Venture capitalActively deployingSouthlake · Seed–Late Stage · 3 people tracked
Investment thesis
Gore Range Capital invests in the decoupling of biological and chronological age, backing companies that extend healthspan and long-term wellbeing. The firm targets next-generation healthcare platforms addressing the root causes of aging, chronic disease, and functional decline, combining scientific discovery with clinical and commercial scalability. A core focus is the skin as a biologically informative, clinically accessible gateway into broader health and aging pathways such as inflammation, immune health, microbiome balance, and regenerative repair. It blends private equity operational discipline with a venture-style scientific partnership model, leveraging domain expertise, global clinical networks, and multidisciplinary partnerships to drive durable value creation.
Source: firm website, verified Aug 3, 2026.
Team · 3 people
from public directories
What they invest in
from 3 of 4 portfolio companiesHealthtech ×3AI & Machine Learning ×1Biotech ×1Digital Health ×1Medical Devices ×1
HQs:United States×4
Investments · 4 tracked
founders shown can be your intro pathHealthtechLee'S Summit, US
Cory Zuehlsdorf(Executive Officer, Director)Ethan Rigel(Director)Cristian Saez(Executive Officer, Director)Charles Hughes(Director)Pierre-Edouard Sottas(Executive Officer)Jean-Marc Leroux(Executive Officer, Director)
Board seatEthan Rigel· per SEC Form D · $6M raise · filed Mar 2019
Southlake, US
Ethan Geldon Rigel(Manager of GRC NVQ Holdings LLC)
Board seatEthan Geldon Rigel· per SEC Form D · filed Jul 2025
HealthtechBrighton, US
Raymond Rackley(Director)Steven Jones(Executive Officer, Director)Jeffrey Jones(Director)
Board seatEthan Rigel· per SEC Form D · $3M raise · filed Oct 2025
AOA Dx develops a blood-based liquid biopsy platform using mass spectrometry and machine learning to detect ovarian cancer at early stages through tumor-associated biomarkers in serum.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesDenver, US
Oriana Papin-Zoghbi(Founder)inAlex Fisher(Founder/COO)inAnna Jeter(Founder)inAbigail Mcelhinny(Executive Officer)Oriana Zoghbi-Harb(Executive Officer, Director)
BoardSurbhi Sarna(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does Gore Range Capital invest at?
- Gore Range Capital invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is Gore Range Capital's typical check size?
- Gore Range Capital typically writes checks of $500K – $5M.
- What sectors does Gore Range Capital focus on?
- Gore Range Capital focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices, Wellness & Fitness.
- Where is Gore Range Capital located?
- Gore Range Capital is headquartered in Southlake, US.
Images
Similar investors
Portfolia operates thematic venture capital funds designed for women investors, backing companies in areas such as women's health, longevity, active aging, greentech, and fintech, while offering an educational and community-driven investing experience.
Tenmile is an Australia-based venture firm investing in health and life sciences companies from seed stage onward, aiming to connect Australian innovation to global markets.
JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.
Equitage Ventures is an early-stage investor focused on companies addressing the physical, mental, spiritual, and social needs of older adults across the senior care continuum.
Obvious is a venture capital firm focused on supporting founders building solutions to humanity's largest challenges across planetary health, human health, and economic health.